Dermatology
News, opinions and meeting coverage in dermatology.
Latest in Dermatology
Meta-analysis suggests lower risk of suicide attempts years after starting isotretinoin
Roundtable of experts weigh in on "unprecedented" efficacy, and safety issues
FDA should consider warning labels based on study results, researchers argue
Prescribing information changed for levetiracetam, clobazam
FDA should consider warning labels based on study results, researchers argue
Prescribing information changed for levetiracetam, clobazam
Dermatology Case Studies
Treatment-resistant juvenile dermatomyositis resolved by targeting elevated interferon-beta

Incision sites were itchy, painful, red, and oozing and were not showing signs of healing

Clinicians consider a number of differential diagnoses before making the call

More in Dermatology
A 51-year-old man visited his doctor concerned about an asymptomatic rash that developed over his face within the last month. Can you diagnose the patient?

Our panel of experts discuss the appropriate time to introduce systemic therapy or switch agents

Treatment-resistant juvenile dermatomyositis resolved by targeting elevated interferon-beta

We've got great treatments, says Steven Feldman, the key is getting patients to use them

James Del Rosso, DO, says to keep an open mind when determining the best option for patients

A 42-year-old woman presented to the ED noting that she felt a stinging sensation on her arm while she was cleaning and organizing her basement, the previous day. Can you diagnose the patient?

Off-label use along with antihistamines improved activity, itch, and wheal count scores
